基本信息
浏览量:242
职业迁徙
个人简介
Dr. Hahn is an internationally recognized authority in the conduct of bladder cancer novel therapeutic clinical trials and translational investigations. He maintains an active clinical practice and sees patients with urothelial cancers of all locations and stages including non-muscle invasive bladder cancer. He is one of the few oncologists in the world leading a clinical trial in non-muscle invasive bladder cancer. In addition, Dr. Hahn continues to care for patients with non-urothelial genitourinary malignancies including prostate, testicular, and other rare tumors. Dr. Hahn's clinical and translational research interests focus on improving outcomes for patients with urothelial cancers through:
The identification and validation of predictive biomarkers relevant to urothelial cancers, and The identification of novel therapeutic and preventative targets for urothelial cancer patients. In addition to his efforts at Johns Hopkins, Dr. Hahn serves as the bladder cancer chairman of the Eastern Cooperative Oncology Group (ECOG), co-chairs the Hoosier Cancer Research Network genitourinary oncology clinical trials working group, participates on the NCI Bladder Cancer Task Force, and serves on the scientific advisory board of the Bladder Cancer Advocacy Network.
He is currently conducting clinical trials to test new therapies for bladder cancer, including those for early stage bladder cancer.
The identification and validation of predictive biomarkers relevant to urothelial cancers, and The identification of novel therapeutic and preventative targets for urothelial cancer patients. In addition to his efforts at Johns Hopkins, Dr. Hahn serves as the bladder cancer chairman of the Eastern Cooperative Oncology Group (ECOG), co-chairs the Hoosier Cancer Research Network genitourinary oncology clinical trials working group, participates on the NCI Bladder Cancer Task Force, and serves on the scientific advisory board of the Bladder Cancer Advocacy Network.
He is currently conducting clinical trials to test new therapies for bladder cancer, including those for early stage bladder cancer.
研究兴趣
论文共 354 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Michael E. Rezaee, Katherine Rodriguez-Mahon,Bruce J. Trock, The-Hung Edward Nguyen,Armine K. Smith,Noah M. Hahn,Sunil H. Patel,Max Kates
Urologic Oncology: Seminars and Original Investigations (2024)
Jean Hoffman-Censits,Petros Grivas,Thomas Powles,Jessica Hawley, Karin Tyroller, Sonja Seeberger,Silke Guenther, Natalia Jacob,Keyvan Tadjalli Mehr,Noah M. Hahn
Sunil H. Patel,Andrew T. Gabrielson, Sin Chan, Deborah Schwartz, Connie Collins,Nirmish Singla,Bruce Trock,Trinity J. Bivalacqua,Noah Hahn,Max R. Kates
Evangelia Vlachou,Andres Matoso,David McConkey,Yuezhou Jing,Burles Avner Johnson,Noah M. Hahn,Jean Hoffman-Censits
Gopa Iyer,Arlene Siefker-Radtke,Matthew Milowsky, Neal Shore, Xin Gao, Melissa A. Reimers,Noah Hahn, Rasha Cosman, Nobuaki Matsubara,Andrea Necchi, Debbie Robbrecht, Armelle Vinceneux,
CANCER RESEARCHno. 8 (2023)
引用0浏览0引用
0
0
Evangelia Vlachou,Noah M. Hahn, Alix Dabb,Burles Avner Johnson, M. Susan Lefande, Jean H. Hoffman-Censits
Journal of Clinical Oncologyno. 6_suppl (2023): 523-523
crossref(2023)
Pranjal Agrawal, Mary Rostom,Ridwan Alam,Isabella Florissi,Michael Biles, Katherine Rodriguez,Noah M. Hahn,Burles A. Johnson Iii,Andres Matoso,Armine Smith,Trinity J. Bivalacqua,Max Kates,
Journal of Urologyno. 6 (2023): 631-638.e1
Akira Ooki, Maria Del Carmen Rodriguez Pena,Luigi Marchionni,Wikum Dinalankara,Asma Begum,Noah M. Hahn, Christopher J. VandenBussche,Zeshaan A. Rasheed,Shifeng Mao,George J. Netto,David Sidransky,Mohammad O. Hoque
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn